ArticleBMJ open2023

Cost-effectiveness analysis of serplulimab combined with chemotherapy in the treatment of extensive-stage small-cell lung cancer from the perspective of the healthcare system in China.

Yunchun Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.